Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02115425 · ClinicalTrials.gov registry record
Calibrate Samsung's BIA to Meseaure Body Composition
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 421
- Enrollment target
NCT02115425 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 421 participants.
The verdict
NCT02115425 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 421 participants
- Enrollment target
Study Summary
The purpose of this study is to collect body composition data using bioimpedance analysis (Samsung) and DXA (GE Medical). Both of the methods are explained in more detail in section 5 of this consent. The data collected will help Samsung improve the products the company offers.
Interventions
- OTHER Body Measurements
- OTHER Whole Body DXA Scan
- OTHER Bioelectrical Impedance Analysis (BIA)
- OTHER add name here
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 421 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02115425
The ClinicalTrials.gov registry entry for NCT02115425 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 421 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Body Measurements is the first listed.
NCT02115425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02115425 about?
NCT02115425 is a clinical study titled "Calibrate Samsung's BIA to Meseaure Body Composition". The purpose of this study is to collect body composition data using bioimpedance analysis (Samsung) and DXA (GE Medical). Both of the methods are explained in more detail in section 5 of this consent. The data collected will help Samsung improve the products the company offers.
What is the current status of trial NCT02115425?
This trial is currently completed. The enrollment target is 421 participants. The study started on 2014-04. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02115425?
The interventions under investigation include: Body Measurements (OTHER), Whole Body DXA Scan (OTHER), Bioelectrical Impedance Analysis (BIA) (OTHER), add name here (OTHER).
Who is sponsoring clinical trial NCT02115425?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.